Previous studies have shown that STING activation occurs rapidly but is subsequently down-regulated due to lysosomal degradation of STING, and inhibiting this degradation enhances IFN-I signaling and the anti-tumor response [32,33]. The gene discussed is STING1; the disease is neoplasm.